merged_colon-cancer-blood-test-shield.txt
<other>Answers are based solely on the provided article.</other>
<question_number>1</question_number>
<answer>Poor at finding precancerous growths (large polyps); only 13% detection of large polyps</answer>
<question_number>2</question_number>
<answer>Colonoscopy to find and remove the cancer or polyp</answer>
<question_number>3</question_number>
<answer>It is a simple routine blood test easier to obtain than a colonoscopy or fecal-sample test</answer>
<question_number>4</question_number>
<answer>It poorly detects precancerous polyps, limiting its ability to prevent cancer</answer>
<question_number>5</question_number>
<answer>The advisory committee approved it because it may prompt people who avoid or forget screening to be screened despite its inability to prevent cancer</answer>
<question_number>6</question_number>
<answer>May still require a follow-up colonoscopy if positive, sharing colonoscopy-related burdens while adding poor polyp detection</answer>
<question_number>7</question_number>
<answer>Low detection rate of precancerous polyps (only 13% of large polyps found)</answer>
<question_number>8</question_number>
<answer>Is easy to obtain and may increase screening uptake but has low polyp detection, hindering cancer prevention</answer>
<question_number>9</question_number>
<answer>Poor detection of precancerous growths compared with other screening tests (13% vs 95% for colonoscopy)</answer>
<question_number>10</question_number>
<answer>Because it may encourage more people who avoid or forget screening to get screened</answer>
<other>No additional information.</other>